84 Geschäftsbericht 2020 Lindenhofgruppe Lehre und Forschung A long-term Extension Study to Evaluate the Safety of Filgonitib in Subjects with Ulcerative Coli-tis (Gilead GSUS-418-3899) Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgonitib in the Induction and Maintenance of Remission in Subject with Moderately to Severely Active Crohn’s Disease (Gilead_ GSUS-419-3895_MC) A Long-Term Extension Study to Evaluate the Safety of Filgonitib in Subjects with Crohn’s Disease (Gilead_GSUS-419-3896_ MC_OL) A Phase III, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Etrolizumab as an Induction and Maintenance Treatment for Patients with Moderately to Severely Active Crohn’s Disease (ETRO_144) An Open-Label Extension and Safety Monitoring Study of Patients with Moderately to Severely Active Crohn’s Disease Previously Enrolled in the Etrolizumab Phase III (ETRO_145) An Open-Label Extension and Safety Monitoring Study of Moderate to Severe Ulcerative Colitis Patients Previously Enrolled in Etrolizumab Phase II/III Studies (ETRO_951) A multicenter, observational cohort study of women undergoing Immediate breast Reconstruction following Mastectomy (IRMA) SLC7-mediated amino acid transport across the materno-fetal barrier: association to human disease Revisiting the steroidogenic pathways in human placenta and primary human trophoblast cells Materno-fetal transport of iron: association with human gestational diseases Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperationspartner/ Sponsor Gastroenterologie Prof. Dr. med. Frank Seibold Gilead Gastroenterologie Prof. Dr. med. Frank Seibold Gilead Gastroenterologie Prof. Dr. med. Frank Seibold Gilead Gastroenterologie Prof. Dr. med. Frank Seibold Hoffmann-La Roche/ Genentech Gastroenterologie Prof. Dr. med. Frank Seibold Hoffmann-La Roche/ Genentech Gastroenterologie Prof. Dr. med. Frank Seibold Hoffmann-La Roche/ Genentech Gynäkologie und Dr. med. Ives Brühlmann Spital Thurgau, Brustzentrum, Geburtshilfe Campus Stiftung Lindenhof Bern (SLB) Gynäkologie und Dr. med. Ruedi Moser-Hässig Institut für Biochemie und Molekulare Geburtshilfe Medizin der Universität Bern Gynäkologie und Dr. med. Ruedi Moser-Hässig Institut für Biochemie und Molekulare Geburtshilfe Medizin der Universität Bern Gynäkologie und Dr. med. Ruedi Moser-Hässig Institut für Biochemie und Molekulare Geburtshilfe Medizin der Universität Bern
RkJQdWJsaXNoZXIy MzQxOTE=